DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo
Authors:
- João LeandroJLJoão Leandro
- Tetyana DodatkoTDTetyana Dodatko
- Jan AtenJAJan Aten
- Natalia S NemeriaNNNatalia S Nemeria
- Xu ZhangXZXu Zhang
- Frank JordanFJFrank Jordan
- Ronald C HendricksonRHRonald C Hendrickson
- Roberto SanchezRSRoberto Sanchez
- Chunli YuCYChunli Yu
- Robert J DeVitaRDRobert J DeVita
- Sander M HoutenSHSander M Houten
Open Access
- 8 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 29 (7) , 1168-1179
Abstract
Glutaric aciduria type 1 (GA1) is an inborn error of lysine degradation characterized by a specific encephalopathy that is caused by toxic accumulation of lysine degradation intermediates. Substrate reduction through inhibition of DHTKD1, an enzyme upstream of the defective glutaryl-CoA dehydrogenase, has been investigated as a potential therapy, but revealed the existence of an alternative enzymatic source of glutaryl-CoA. Here, we show that loss of DHTKD1 in glutaryl-CoA dehydrogenase-deficient HEK-293 cells leads to a 2-fold decrease in the established GA1 clinical biomarker glutarylcarnitine and demonstrate that oxoglutarate dehydrogenase (OGDH) is responsible for this remaining glutarylcarnitine production. We furthermore show that DHTKD1 interacts with OGDH, dihydrolipoyl succinyltransferase and dihydrolipoamide dehydrogenase to form a hybrid 2-oxoglutaric and 2-oxoadipic acid dehydrogenase complex. In summary, 2-oxoadipic acid is a substrate for DHTKD1, but also for OGDH in a cell model system. The classical 2-oxoglutaric dehydrogenase complex can exist as a previously undiscovered hybrid containing DHTKD1 displaying improved kinetics towards 2-oxoadipic acid.Keywords
All Related Versions
Funding Information
- the Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health (R03HD092878, R21HD088775, UL1TR001433)
- National Center for Advancing Translational Sciences
- National Institutes of Health (R15GM116077)
This publication has 46 references indexed in Scilit:
- Genetic basis of hyperlysinemiaOrphanet Journal of Rare Diseases, 2013
- DHTKD1 Mutations Cause 2-Aminoadipic and 2-Oxoadipic AciduriaThe American Journal of Human Genetics, 2012
- Differential expression of interleukin‐17 family cytokines in intact and complicated human atherosclerotic plaquesThe Journal of Pathology, 2009
- Metabolism of lysine in α‐aminoadipic semialdehyde dehydrogenase‐deficient fibroblasts: Evidence for an alternative pathway of pipecolic acid formationFEBS Letters, 2009
- Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type IBrain, 2009
- Structure–function relationships in the 2‐oxo acid dehydrogenase family: Substrate‐specific signatures and functional predictions for the 2‐oxoglutarate dehydrogenase‐like proteinsProteins: Structure, Function, and Bioinformatics, 2007
- Bioenergetics in Glutaryl-Coenzyme A Dehydrogenase DeficiencyJournal of Biological Chemistry, 2005
- Kinetic properties of the 2‐oxoglutarate dehydrogenase complex from Azotobacter vinelandiiEuropean Journal of Biochemistry, 2000
- A G-to-T transversion at the +5 position of intron 1 in the glutaryl CoA dehydrogenase gene is associated with the island Lake variant of glutaric acidemia type IHuman Molecular Genetics, 1995
- Tryptophan and lysine metabolism in alpha‐aminoadipic aciduriaAmerican Journal of Medical Genetics, 1980